<?xml version='1.0' encoding='utf-8'?>
<document id="11221290"><sentence text="Barnidipine, a long-acting slow onset calcium antagonist."><entity charOffset="0-11" id="DDI-PubMed.11221290.s1.e0" text="Barnidipine" /><entity charOffset="38-45" id="DDI-PubMed.11221290.s1.e1" text="calcium" /><pair ddi="false" e1="DDI-PubMed.11221290.s1.e0" e2="DDI-PubMed.11221290.s1.e0" /><pair ddi="false" e1="DDI-PubMed.11221290.s1.e0" e2="DDI-PubMed.11221290.s1.e1" /></sentence><sentence text="Barnidipine is a stereochemically pure dihydropyridine calcium antagonist with a high potency"><entity charOffset="0-11" id="DDI-PubMed.11221290.s2.e0" text="Barnidipine" /><entity charOffset="39-62" id="DDI-PubMed.11221290.s2.e1" text="dihydropyridine calcium" /><pair ddi="false" e1="DDI-PubMed.11221290.s2.e0" e2="DDI-PubMed.11221290.s2.e0" /><pair ddi="false" e1="DDI-PubMed.11221290.s2.e0" e2="DDI-PubMed.11221290.s2.e1" /></sentence><sentence text=" The drug showed a slow onset and long-lasting vasorelaxating effect in vitro, and strong antihypertensive activity in hypertension models" /><sentence text=" Barnidipine was shown to have a high vasoselectivity and offered protection in cardiac and renal ischaemia models"><entity charOffset="1-12" id="DDI-PubMed.11221290.s4.e0" text="Barnidipine" /></sentence><sentence text=" The in vitro drug:drug interaction profile suggests a low potential for clinically relevant interactions with concomitant medication" /><sentence text=" It can be anticipated that barnidipine is an attractive calcium antagonist, offering good blood pressure control without compensatory baroreflex activity"><entity charOffset="28-39" id="DDI-PubMed.11221290.s6.e0" text="barnidipine" /><entity charOffset="57-64" id="DDI-PubMed.11221290.s6.e1" text="calcium" /><pair ddi="false" e1="DDI-PubMed.11221290.s6.e0" e2="DDI-PubMed.11221290.s6.e0" /><pair ddi="false" e1="DDI-PubMed.11221290.s6.e0" e2="DDI-PubMed.11221290.s6.e1" /></sentence><sentence text="" /></document>